Meihua International Medical Technologies Co Ltd stock analysis
Want to see MHUAF full AI Analyst Report?
Meihua International Medical Technologies Co Ltd (MHUAF) Stock Price & Analysis
MHUAF Stock Chart & Stats
- Day’s Range
- $5.50 - $6.00
- 52-Week Range
- $2.05 - $25.96
- Previous Close
- $6.00
- Volume
- N/A
- Average Volume (3M)
- 64
- Market Cap
- $4.93M
- Enterprise Value
- -$373.79B
- Total Cash (Recent Filing)
- $15.15M
- Total Debt (Recent Filing)
- $8.99M
- Price to Earnings (P/E)
- 0.4
- Beta
- 0.88
- Next Earnings
- Nov 16, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Low Financial Leverage
The company’s modest debt relative to its equity base provides financial resilience and limits interest-related pressure. This conservative funding structure preserves flexibility to support operations, invest in products, or withstand weaker demand without relying heavily on external financing.
Growing Capital Base
A steadily expanding equity and asset base indicates that the business has accumulated meaningful financial resources over time. This provides a stable foundation for continued operations and gives the company greater capacity to absorb volatility in earnings or cash generation.
Recurring Consumables Demand
The focus on disposable medical supplies aligns revenue with recurring clinical usage because single-use products must be replenished as patient care continues. That consumption-based model can support repeat purchasing and provide a durable demand foundation across healthcare providers and distributors.
Bears Say
Sharp Revenue Decline
The substantial revenue contraction signals weakening demand, reduced sales volumes, pricing pressure, or some combination of these factors. Unless reversed, a smaller revenue base can reduce operating leverage, limit investment capacity, and make future earnings more vulnerable to customer and market fluctuations.
Margin And Profit Compression
Lower gross margins and declining net income show that profitability has weakened alongside sales. This reduces the earnings produced by each dollar of revenue and may constrain reinvestment, making sustained recovery more dependent on restoring pricing, product mix, or operating efficiency.
Unreliable Cash Generation
The sharp deterioration in operating and free cash flow indicates that reported profits have not converted consistently into cash. Weak cash durability can restrict self-funded growth, reduce financial flexibility, and increase the importance of maintaining the company’s conservative balance-sheet position.
Meihua International Medical Technologies Co Ltd News
MHUAF FAQ
What was Meihua International Medical Technologies Co Ltd’s price range in the past 12 months?
What is Meihua International Medical Technologies Co Ltd’s market cap?
When is Meihua International Medical Technologies Co Ltd’s upcoming earnings report date?
How were Meihua International Medical Technologies Co Ltd’s earnings last quarter?
Is Meihua International Medical Technologies Co Ltd overvalued?
Does Meihua International Medical Technologies Co Ltd pay dividends?
What is Meihua International Medical Technologies Co Ltd’s EPS estimate?
How many shares outstanding does Meihua International Medical Technologies Co Ltd have?
What happened to Meihua International Medical Technologies Co Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Meihua International Medical Technologies Co Ltd?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Meihua International Medical Technologies Co Ltd
Meihua International Medical Technologies Co., Ltd. is a Chinese company dedicated to the innovation, production, and distribution of a wide array of medical devices. Operating primarily within the People's Republic of China, its comprehensive product portfolio spans various regulatory classifications. The company offers numerous Class I disposable medical supplies, such as medical X-ray and dry films, dry laser imagers, gauze bandages, and examination gloves. It also provides pharmaceutical packaging, including low-density polyethylene eye drop bottles and high-density polyethylene tablet bottles. Its Class II inventory comprises critical disposable instruments and kits for medical procedures, including complete anesthesia kits, specialized medical brushes, various examination and urethral catheterization sets, endotracheal intubation devices, medical masks, anal bags, and suction connecting tubes. For Class III disposable medical devices, Meihua manufactures advanced solutions like single-use infusion pumps, sophisticated anesthesia puncture kits, and electronic pump systems. Beyond these, the company also produces disposable plastic baby bottles and components like NB/PSN rubber covers and 8.2mL folded spoons for tools and containers. It specializes in Class II 6866 medical polymer materials and products, such as transfusion equipment, pipelines, and endotracheal intubation for respiratory care, alongside traditional medical X-ray films and multi-functional self-extracting X-ray film machines. Meihua caters to a broad customer base, including hospitals, pharmacies, medical institutions, and medical equipment companies. Its products are distributed globally, reaching markets throughout Europe, North America, South America, Asia, Africa, and Oceania. Founded in 1991, the company is headquartered in Yangzhou, People's Republic of China.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Lee Leyi
- Employees
- 486
- Website
- www.meihuamed.com
- Address
- 88 Tongda Road, Yangzhou, JS, 225000, CN
Meihua International Medical Technologies Co Ltd (MHUAF) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |
